Shanghai Labway Clinical Laboratory Co., Ltd (SHE:301060)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Sales of in Vitro Diagnostic Products	709.04M	944.77M	1.02B	922.91M	819.20M
Sales of in Vitro Diagnostic Products Growth	-24.95%	-7.46%	10.62%	12.66%	7.44%
Medical Diagnostic Services	738.24M	797.17M	646.76M	3.26B	947.22M
Medical Diagnostic Services Growth	-7.39%	23.26%	-80.15%	244.05%	102.02%
Unallocated Other Operations	761.58K	247.32K	6.72M	17.50M	11.91M
Unallocated Other Operations Growth	207.94%	-96.32%	-61.58%	46.94%	74.30%
Total	1.45B	1.74B	1.67B	4.20B	1.78B
Total Growth	-16.88%	4.05%	-60.13%	136.14%	43.62%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
China	1.45B	1.74B	1.67B	4.20B	1.78B
China Growth	-16.88%	4.05%	-60.13%	136.14%	43.62%
Total	1.45B	1.74B	1.67B	4.20B	1.78B
Total Growth	-16.88%	4.05%	-60.13%	136.14%	43.62%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 21, 2026

Data Sources Report a data error